The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
Open accessAbstract
NY-ESO-1 is a “cancer-testis” antigen expressed in many cancers. ISCOMATRIX is a saponin-based adjuvant that induces antibody and T cell responses. We performed a placebo-controlled clinical trial evaluating the safety and immunogenicity of recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant. Forty-six evaluable patients with resected NY-ESO-1-positive tumors received three doses of vaccine intramuscularly at monthly intervals. The vaccine was well tolerated. We observed high-titer antibody responses, strong delayed-type hypersensitivity reactions, and circulating CD8+ and CD4+ T cells specific for a broad range of NY-ESO-1 epitopes, including known and previously unknown epitopes. In an unplanned analysis, vaccinated patients appeared to have superior clinical outcomes to those treated with placebo or protein alone. The vaccine is safe and highly potent immunologically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of intracellular cytokines by flow cytometry
Jung, T., Schauer, U., Heusser, C., Neumann, C., & Rieger, C. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90158-4 · Cited by 975
Jäger, E., Chen, Y.-T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jäger, D., Arand, M., Wada, H., Noguchi, Y., Stockert, E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.265 · Cited by 725
Self-citationA Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
Stockert, E., Jäger, E., Chen, Y.-T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., & Old, L. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1349 · Cited by 698
Self-citationThe cancer/testis genes: review, standardization, and commentary.
Scanlan, M. J., Simpson, A. J. G., & Old, L. J. (2004) · PubMed · Cited by 667
Self-citationJäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413497 · Cited by 426
Self-citationMonitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
Jäger, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jäger, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4760 · Cited by 398
Self-citationTao, M.-H., & Levy, R. (1993) · Nature · doi:10.1038/362755a0 · Cited by 302
LAGE-1, a new gene with tumor specificity
Lethé, B., Lucas, S., Michaux, L., Smet, C. D., Godelaine, D., Serrano, A., Plaen, E. D., & Boon, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980610)76:6<903::aid-ijc22>3.0.co;2-1 · Cited by 264
Karanikas, V, Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V, Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119825 · Cited by 263
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
Fong, L., Brockstedt, D., Benike, C., Breen, J. K., Strang, G., Ruegg, C. L., & Engleman, E. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7150 · Cited by 252
Jäger, E., Jäger, D., Karbach, J., Chen, Y.-T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L. J., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.625 · Cited by 229
Self-citationWang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3596 · Cited by 204
Gnjatic, S., Atanackovic, D., Jäger, E., Matsuo, M., Selvakumar, A., Altorki, N. K., Maki, R. G., Dupont, B., Ritter, G., Chen, Y.-T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133324100 · Cited by 203
Self-citationZeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., & Wang, R.-F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061507398 · Cited by 193
Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients
Atanackovic, D., Altorki, N. K., Stockert, E., Williamson, B., Jungbluth, A. A., Ritter, E., Santiago, D., Ferrara, C. A., Matsuo, M., Selvakumar, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3289 · Cited by 184
Self-citationMarchand, M., Punt, C. J. A., Aamdal, S., Escudier, B., Kruit, W. H. J., Keilholz, U., Håkansson, L., van Baren, N., Humblet, Y., Mulders, P., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00479-3 · Cited by 169
Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules
Zeng, G., Touloukian, C. E., Wang, X., Restifo, N. P., Rosenberg, S. A., & Wang, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1153 · Cited by 151
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
Zarour, H. M., Storkus, W. J., Brusić, V., Williams, E., & Kirkwood, J. M. (2000) · PubMed · Cited by 127
Chen, W., Yewdell, J. W., Levine, R. L., & Bennink, J. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1757 · Cited by 119
Self-citationTimmerman, J. M., & Levy, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4797 · Cited by 112
Ennis, F. A., Cruz, J., Jameson, J., Klein, M. H., Burt, D. S., & Thipphawong, J. (1999) · Virology · doi:10.1006/viro.1999.9765 · Cited by 109
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
Gnjatic, S., Nagata, Y., Jäger, E., Stockert, E., Shankara, S., Roberts, B., Mazzara, G. P., Lee, S. Y., Dunbar, P. R., Dupont, B., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10917 · Cited by 104
Self-citationChen, Q., Jackson, H. M., Parente, P., Luke, T., Rizkalla, M., Tai, T. Y., Zhu, H., Mifsud, N. A., Dimopoulos, N., Masterman, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403271101 · Cited by 89
Self-citationRimoldi, D., Rubio‐Godoy, V., Dutoit, V., Líénard, D., Salvi, S., Guillaume, P., Speiser, D. E., Stockert, E., Spagnoli, G. C., Servis, C., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7253 · Cited by 85
Fernando, G. J. P., Murray, B. E., ZHOU, J., & Frazer, I. H. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00813.x · Cited by 58
Zhang, Y., Chaux, P., Stroobant, V., Eggermont, A. M. M., Corthals, J., Maillère, B., Thielemans, K., Marchand, M., Boon, T., & van der Bruggen, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.219 · Cited by 50
Cited by
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Cancer/testis antigens, gametogenesis and cancer
Simpson, A. J. G., Caballero, O. L., Jungbluth, A., Chen, Y.-T., & Old, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1669 · Cited by 1,582
Self-citationTowards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067
HUMAN T CELL RESPONSES AGAINST MELANOMA
Boon, T., Coulie, P. G., Eynde, B. J. V. D., & Bruggen, P. V. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090733 · Cited by 651
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Metadata
- Authors
- Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T., Murphy, R., Scott, A. M., Maraskovsky, E., McArthur, G., MacGregor, D., Sturrock, S., Tai, T. Y., Green, S., Cuthbertson, A., Maher, D., Miloradovic, L., Mitchell, S. V., Ritter, G., Jungbluth, A. A., Chen, Y.-T., Gnjatic, S., Hoffman, E. W., Old, L. J., & Cebon, J. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-07-13
- Volume
- 101
- Issue
- 29
- Pages
- 10697-10702
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2150835657
- Cited by
- 440
- References
- 26
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.